cd38 inhibitor and 5-amino-1mq synergy nad+ is a key mediator of depletion in the brain of ZIKV-infected mice: iScience The Pharmacology of CD38/NADase: An
The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline ScienceDirect Frontiers CD38 in Adenosinergic Pathways and Metabolic Re programming in Human Multiple Myeloma Cells: In tandem Insights From Basic Science to Therapy Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect The CD38 glycohydrolase and the NAD sink: implications for pathological conditions American Journal of Physiology Cell Physiology American Physiological Society
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18




